Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

(2010) Jiun-Ling Wang et al.   BMC INFECTIOUS DISEASES

Relationship of Vancomycin Minimum Inhibitory Concentration to Mortality in Patients With Methicillin-Resistant Staphylococcus aureus Hospital-Acquired, Ventilator-Associated, or Health-care-Associated Pneumonia

(2010) Nadia Z. Haque et al.   CHEST

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

(2010) Y. K. Yoon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study

(2010) E. Goldberg et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan

(2010) S.-H. Lin et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study

(2010) Marin L. Schweizer et al.   PLoS One

Adequacy of Antimicrobial Treatment and Outcome ofStaphylococcus aureusBacteremia in 9 Western European Countries

(2009) Heidi Ammerlaan et al.   CLINICAL INFECTIOUS DISEASES

Clinical Consensus Conference: Survey on Gram‐Positive Bloodstream Infections with a Focus onStaphylococcus aureus

(2009) Christoph K. Naber et al.   CLINICAL INFECTIOUS DISEASES

Case–control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia

(2009) D. Marchaim et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia*

(2009) Young Ju Jung et al.   CRITICAL CARE MEDICINE

Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections

(2009) Carol L. Moore et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom

(2009) F. K. Gould et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of inappropriate empirical therapy for sepsis due to health care-associated methicillin-resistant Staphylococcus aureus

(2009) Jesús Rodríguez-Baño et al.   JOURNAL OF INFECTION

Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia

(2008) M. Y. Lin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007

(2008) Alicia I. Hidron et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES